The diagnosis of dysplasia and malignancy in Barrett's oesophagus (Q33994505)

30 July 2017

1 reference

title

The diagnosis of dysplasia and malignancy in Barrett's oesophagus (English)

1 reference

30 July 2017

Geboes K

1

1 reference

30 July 2017

Van Eyken P

series ordinal

2

1 reference

30 July 2017

publication date

1 August 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

37

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

99-107

1 reference

Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Do pathologists play dice? Uncertainty and early histopathological diagnosis of common malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Dysplasia in inflammatory bowel diseases: definition and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Gastric epithelial dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Polypoid dysplasia in Barrett's esophagus: a clinicopathologic, immunohistochemical, and molecular study of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Usefulness of cytopathology and histology in the evaluation of Barrett's esophagus in a community hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Laser‐Induced Fluorescence for Esophageal Cancer and Dysplasia Diagnosisa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Acidic fibroblast growth factor is progressively increased in the development of oesophageal glandular dysplasia and adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Potential application of p53 as an intermediate biomarker in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Barrett's esophagus, dysplasia, and adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Expression of CD44H and CD44v3 in normal oesophagus, Barrett mucosa and oesophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Expression of CD44 in premalignant and malignant Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Diagnostic value of p53 immunohistochemistry in Barrett's esophagus: an endoscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

High-grade dysplasia in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

Abnormal expression of growth regulatory factors in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2559.2000.00960.X

10.1046/J.1365-2559.2000.00960.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference